Cinclus Pharma (CINPHA) - Cash Flow Conversion Efficiency

Latest as of June 2026: -0.425x

Based on the latest financial reports, Cinclus Pharma (CINPHA) has a cash flow conversion efficiency ratio of -0.425x as of June 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Skr-86.19 Million ≈ $-9.28 Million USD) by net assets (Skr202.70 Million ≈ $21.81 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see market value of Cinclus Pharma for the company's overall valuation and market capitalisation.

Cinclus Pharma - Cash Flow Conversion Efficiency Trend (2022–2025)

This chart illustrates how Cinclus Pharma's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Cinclus Pharma Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Cinclus Pharma ranked by their cash flow conversion efficiency. See cash flow to debt ratio of Cinclus Pharma to evaluate how effectively operating cash flow covers total debt obligations.

Company	Cash Flow Conversion Efficiency
NTPM Holdings Bhd KLSE:5066	0.027x
Univentures Public Company Limited BK:UV	0.077x
T7 Global Bhd KLSE:7228	0.023x
Chilwa Minerals Ltd AU:CHW	-0.071x
Land Securities Group PLC LSE:LAND	0.029x
TETHYS PETROLEUM LTD F:TP21	0.112x
Multifiling Mitra Indonesia JK:MFMI	0.602x
Fiducial Office Solutions PA:SACI	-0.086x

Annual Cash Flow Conversion Efficiency for Cinclus Pharma (2022–2025)

The table below shows the annual cash flow conversion efficiency of Cinclus Pharma from 2022 to 2025. View CINPHA stock price for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	Skr369.39 Million ≈ $39.75 Million	Skr-74.65 Million ≈ $-8.03 Million	-0.202x	+37.08%
2024-12-31	Skr555.33 Million ≈ $59.76 Million	Skr-178.37 Million ≈ $-19.20 Million	-0.321x	-111.79%
2023-12-31	Skr-76.80 Million ≈ $-8.26 Million	Skr-209.19 Million ≈ $-22.51 Million	2.724x	+279.92%
2022-12-31	Skr126.87 Million ≈ $13.65 Million	Skr-192.08 Million ≈ $-20.67 Million	-1.514x	--

About Cinclus Pharma

ST:CINPHA Sweden Drug Manufacturers - Specialty & Generic

Market Cap

$57.79 Million

Skr537.05 Million SEK

Market Cap Rank

#21458 Global

#387 in Sweden

Share Price

Skr11.54

Change (1 day)

-0.52%

52-Week Range

Skr10.82 - Skr19.46

All Time High

Skr42.00